Salicylamide (2-Hydroxybenzamide)
(Synonyms: 水杨酰胺; 2-Hydroxybenzamide) 目录号 : GC33859
Salicylamide (o-hydroxybenzamide) is a non-prescription drug with analgesic and antipyretic properties.
Cas No.:65-45-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Animal experiment: | Rats: Pregnant rats are fed 25% casein diet with or without 2% salicylamide from day 6 to day 17 or day 19 of gestation. The dams are killed on day 17 or day 19 of gestation, 24 hours following an intramuscular injection of sodium 35S-sulfate[2]. |
References: [1]. Kushkevych I, et al. Activity of selected salicylamides against intestinal sulfate-reducing bacteria. Neuro Endocrinol Lett. 2015;36 Suppl 1:106-13. | |
Salicylamide (o-hydroxybenzamide) is a non-prescription drug with analgesic and antipyretic properties.
| Cas No. | 65-45-2 | SDF | |
| 别名 | 水杨酰胺; 2-Hydroxybenzamide | ||
| Canonical SMILES | O=C(N)C1=CC=CC=C1O | ||
| 分子式 | C7H7NO2 | 分子量 | 137.14 |
| 溶解度 | DMSO : ≥ 100 mg/mL (729.18 mM);Water : 0.1 mg/mL (0.73 mM) | 储存条件 | 4°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 7.2918 mL | 36.4591 mL | 72.9182 mL |
| 5 mM | 1.4584 mL | 7.2918 mL | 14.5836 mL |
| 10 mM | 0.7292 mL | 3.6459 mL | 7.2918 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
On the complexation of copper (II) ion with 2-Hydroxybenzamide
Ann Chim 2007 Mar-Apr;97(3-4):187-98.PMID:17822227DOI:10.1002/adic.200790004.
The complexation of the Cu2+ ion with 2-Hydroxybenzamide (Salicylamide, HL) has been studied, at 25 degrees C, by potentiometric measurements with a glass electrode in NaCIO4 media for ionic strength ranging from 0.5 to 3 mol/dm3. The data are consistent with the formation of the complexes CuH(-1)(HL)+, CuH(-2)(HL)2, Cu2H(-2)(HL)2(2+) and CuH(-2)(HL). The minor species, Cu2H(-2)(HL)2(2+) and CuH(-2)(HL), amount to at least 20% of the total copper. Elaboration of the data according to the Specific Interaction Theory yields the constants valid in the infinite dilution reference state: [formulas: see text] and the interaction coefficients (kg/mol) of complex species with medium ions: b(L-,Na+) = 0.11 +/- 0.03; b(CuH(-1)(HL)+,NaClO4) = 0.17 +/- 0.05; b(CuH(-2)(HL)2,NaClO4) = 0.11 +/- 0.05; b(Cu2H(-2)(HL)2(2+),NaClO4) = 0.2(7) +/- 0.1; b(CuH(-2)(HL),NaClO4) = -0.0(3) +/- 0.1.
Therapeutic potential of salicylamide derivatives for combating viral infections
Med Res Rev 2023 Mar 10.PMID:36905090DOI:10.1002/med.21940.
Since time immemorial human beings have constantly been fighting against viral infections. The ongoing and devastating coronavirus disease 2019 pandemic represents one of the most severe and most significant public health emergencies in human history, highlighting an urgent need to develop broad-spectrum antiviral agents. Salicylamide (2-Hydroxybenzamide) derivatives, represented by niclosamide and nitazoxanide, inhibit the replication of a broad range of RNA and DNA viruses such as flavivirus, influenza A virus, and coronavirus. Moreover, nitazoxanide was effective in clinical trials against different viral infections including diarrhea caused by rotavirus and norovirus, uncomplicated influenza A and B, hepatitis B, and hepatitis C. In this review, we summarize the broad antiviral activities of salicylamide derivatives, the clinical progress, and the potential targets or mechanisms against different viral infections and highlight their therapeutic potential in combating the circulating and emerging viral infections in the future.
Propensity of Salicylamide and ethenzamide cocrystallization with aromatic carboxylic acids
Eur J Pharm Sci 2016 Mar 31;85:132-40.PMID:26898408DOI:10.1016/j.ejps.2016.02.010.
The cocrystallization of Salicylamide (2-Hydroxybenzamide, SMD) and ethenzamide (2-ethoxybenzamide, EMD) with aromatic carboxylic acids was examined both experimentally and theoretically. The supramolecular synthesis taking advantage of the droplet evaporative crystallization (DEC) technique was combined with powder diffraction and vibrational spectroscopy as the analytical tools. This led to identification of eleven new cocrystals including pharmaceutically relevant coformers such as mono- and dihydroxybenzoic acids. The cocrystallization abilities of SMD and EMD with aromatic carboxylic acids were found to be unexpectedly divers despite high formal similarities of these two benzamides and ability of the R2,2(8) heterosynthon formation. The source of diversities of the cocrystallization landscapes is the difference in the stabilization of possible conformers by adopting alternative intramolecular hydrogen boding patterns. The stronger intramolecular hydrogen bonding the weaker affinity toward intermolecular complexation potential. The substituent effects on R2,2(8) heterosynthon properties are also discussed.
Salicylamide cocrystals: screening, crystal structure, sublimation thermodynamics, dissolution, and solid-state DFT calculations
J Phys Chem B 2014 Jun 19;118(24):6803-14.PMID:24861612DOI:10.1021/jp5032898.
A new cocrystal of 2-Hydroxybenzamide (A) with 4-acetamidobenzoic acid (B) has been obtained by the DSC screening method. Thermophysical analysis of the aggregate [A:B] has been conducted and a fusion diagram has been plotted. Cocrystal formation from melts was studied by using thermomicroscopy. A cocrystal single-crystal was grown and its crystal structure was determined. The pattern of noncovalent interactions has been quantified using the solid-state DFT computations coupled with the Bader analysis of the periodic electron density. The sublimation processes of A-B cocrystal have been studied and its thermodynamic functions have been calculated. The classical method of substance transfer by inert gas-carrier was chosen to investigate sublimation processes experimentally. The lattice energy is found to be 143 ± 4 kJ/mol. It is lower than the sum of the corresponding values of the cocrystal pure components. The theoretical value of the lattice energy, 156 kJ/mol, is in reasonable agreement with the experimental one. A ternary phase diagram of solubility (A-B-ethanol) has been plotted and the areas with solutions for growing thermodynamically stable cocrystals have been determined.
FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide -- a metabolite of Salicylamide
Acta Pharm 2004 Sep;54(3):163-76.PMID:15610614doi
Gentisamide (GAM, 2,5-dihydroxybenzamide), a minor first-pass metabolite of Salicylamide (SAM, 2-Hydroxybenzamide), was studied using FT-IR, 1D and 2D homo- and heteronuclear 1H and 13C NMR spectroscopy. GAM was isolated from human urine eight hours after oral administration of SAM. FT-IR, 1H and 13C NMR spectra unequivocally confirmed the chemical structure of GAM through chemical and substituent shifts, coupling constants and connectivities in COSY, NOESY, HETCOR and HBMC spectra. From NOESY spectra of GAM in DMSO-d6, it was concluded that the amide protons are oriented toward the ortho-proton at C-6. Obtained results indicate that the presence of the additional phenol group at C-5 in GAM favours the formation of intramolecular hydrogen bonding of the O...HO type between C2-OH proton and oxygen atom of the amide group.